Every year, more than 3,000 scientific abstracts are accepted for oral and poster presentation at the Society's annual meeting.
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research
Hear top experts in hematologic malignancies discuss the latest developments in clinical care.
Register today for the 56th ASH Annual Meeting and Exposition.
December 7, 2014 - run or walk in the ASH Foundation 3K - 5K Run/Walk and help move hematology forward.
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research.
Search a database of practicing hematologists in your area.
Help move hematology forward by supporting research, career development, and quality care and education programs.
Become part of a global network of more than 16,000 hematologists working to conquer blood diseases.
New evidence suggests that therapeutic plasma exchange and appropriate blood testing could help patients who are in urgent need of heart surgery, but have a history of an adverse reaction to the blood thinner heparin, according to a study published online today in Blood, the Journal of the American Society of Hematology.
The American Society of Hematology (ASH), the world’s largest professional society concerned with the causes and treatment of blood disorders, today announced the names of seven recipients of its Bridge Grant awards. These one-year, $150,000 awards provide critical interim support for hematology research proposals that, despite earning high scores, could not be funded by the National Institutes of Health (NIH) amid severe funding reductions. The ASH Bridge Grant award recipients announced today join 44 hematologists that have received funding since ASH committed $9 million in Society funds to create the program in July 2012.
The American Society of Hematology (ASH) today
announced the 20 hematologists and other medical professionals selected to
participate in the 2014 ASH Visitor Training Program. This program provides
talented hematologists, scientists, and laboratory staff from developing
countries the opportunity to receive training on a specific area of hematology
from an ASH member located anywhere in the world for up to 12 weeks. The goal
of this program is to build hematology capacity in developing countries and
ultimately improve the care of patients with blood diseases worldwide.
The American Society
of Hematology (ASH), the world’s largest professional society concerned with
the causes and treatment of blood disorders, today joins the International
Society on Thrombosis and Haemostasis (ISTH) and nearly 200 organizations
worldwide to commemorate October 13, 2014, as the inaugural World Thrombosis
Day, a day dedicated to raising awareness of potentially dangerous blood clots.
ASH staff recently attended an IOM National Cancer Policy Forum workshop on policy issues in the development and adoption of molecularly targeted therapies for cancer. The purpose of this workshop was to examine the recent trends in the development and implementation of molecularly targeted cancer therapies, address current challenges in the field, and to put forth potential strategies and policy action items that could improve current processes.
ASH remains committed to working with various groups
in the sickle cell stakeholder community, Congress, the National Institutes of
Health (NIH), the Centers for Disease Control and Prevention (CDC), and other
federal agencies to increase research, treatment options, and access to care
for patients with sickle cell disease and sickle cell trait. Continue reading about the major initiatives
undertaken by the Society in 2014.
Over the past several years, shortages of drugs and
biologics used to treat patients with hematologic diseases, including leukemia
and lymphoma, have become critical and life-threatening. ASH has taken a number of steps to resolve
these drug and biologic shortages, including working with manufacturers, the
Food & Drug Administration (FDA) and Congress. ASH continues to be actively involved in this
issue. Continue reading for a summary of recent ASH advocacy efforts to address
drug and biologic shortages.
During 2014, ASH has
continued to be one of the most visible advocates for federal support of
biomedical research and funding for the National Institutes of Health (NIH). Continue reading for a summary of ASH's 2014 advocacy efforts.
Dr. Bertuch and Dr. Kurre examine the need for improvement in how acquired aplastic anemia is both diagnosed and treated in the United States.
This fall, ASH will begin publishing a monthly news magazine specifically designed to appeal to clinical practitioners in hematology and oncology. ASH Clinical News will provide timely updates in the field by reporting on key medical meetings, clinical trials, innovative technology, and influential papers in the literature.
Dr. Gilbert White chronicles his involvement in the HIV and HCV epidemics that devastated the hemophilia population in the 1980s, highlighting the power of science and the resilience of patients, physicians, and scientists, who faced adversity and triumphed.
It's not to early to plan to attend the annual meeting. Read about what's in store for this year's program.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology